Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1144320160480020081
°¨¿°°ú È­Çпä¹ý
2016 Volume.48 No. 2 p.81 ~ p.90
Prolonged versus Intermittent Infusion of ¥â-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis
Lal Ashima

Jaoude Philippe
El-Solh Ali-A.
Abstract
Background: The primary objective of this meta-analysis is aimed at determining whether ¥â-lactams prolonged infusion in patients with nosocomial pneumonia (NP) results in higher cure rate and improved mortality compared to intermittent infusion.

Materials and Methods: Relevant studies were identified from searches of MEDLINE, EMBASE, and CENTRAL from inception to September 1st, 2015. All published articles which evaluated the outcome of extended/continuous infusion of antimicrobial therapy versus intermittent infusion therapy in the treatment of NP were reviewed.

Results: A total of ten studies were included in the analysis involving 1,051 cases of NP. Prolonged infusion of ¥â-lactams was associated with higher clinical cure rate (OR 2.45, 95% CI, 1.12, 5.37) compared to intermittent infusion. However, there was no significant difference in mortality (OR 0.85, 95% CI 0.63?1.15) between the two groups. Subgroup analysis for ¥â-lactam subclasses and for severity of illness showed comparable outcomes.

Conclusion: The limited data available suggest that reduced clinical failure rates when using prolonged infusions of ¥â-lactam antibiotics in critically ill patients with NP. More detailed studies are needed to determine the impact of such strategy on mortality in this patient population.
KEYWORD
Prolonged infusion, ¥â-lactams, Clinical cure, Mortality
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø